Susan Moench, PhD, PA-C, Author at Cancer Therapy Advisor - Page 49 of 49
Susan Moench, PhD, PA-C

Susan Moench, PhD, PA-C

Oncology Writer https://www.cancertherapyadvisor.com
Susan Moench has been working as a medical writer since 2003. Prior to joining the staff of Cancer Therapy Advisor and Oncology Nurse Advisor as an oncology writer, she spent approximately 4 years as a medical writer at the Rutgers Cancer Institute of New Jersey, where she collaborated with oncologists on clinical trial protocols and publications related to precision oncology. Previous positions included approximately 5 years as an oncology scientist/senior medical writer at the National Comprehensive Cancer Network (NCCN), where she contributed to the development and update of clinical practice guidelines covering the diagnosis and treatment of a broad range of malignancies as well as supportive care issues in cancer. Susan received her PhD in Biochemistry from Colorado State University; she also holds an MS in Physician Assistant studies from DeSales University and is a certified physician assistant.

All articles by Susan Moench, PhD, PA-C

Pazopanib may be similar to sunitinib in terms of clinical efficacy for treating metastatic renal ce

Comparing Efficacy and Safety of Auto-HCT in Older and Younger Patients With Multiple Myeloma

The efficacy and safety of autologous hematopoietic stem cell transplantation (auto-HCT) performed during the era of novel agents was comparable between elderly and younger patients with multiple myeloma, according to results of a retrospective study published in Bone Marrow Transplantation. Uncertainty remains regarding the risks and benefits of auto-HCT in elderly patients (≥ 65 years).…

Managing adverse effects after starting a TKI can be challenging, and health care practitioners ofte

Differences in the Diagnosis, Management, and Outcomes of Hispanic Patients With Gastric Cancer Revealed

A retrospective study of patients with gastric cancer in the United States showed differences in patient- and disease-related characteristics, as well as different frequencies of staging laparoscopy, treatment/surgical approaches, and specific clinical outcomes, for those of Hispanic compared with non-Hispanic ethnicity. This study was published in the Journal of Surgical Oncology. In the US, the incidence of gastric…

The #MeToo movement has inspired many women to relate stories of harassment, and medicine is no exce

Female Representation on NCCN Guideline Panels Suggests Low Gender Bias

A significant linear relationship was observed in a study investigating whether the proportion of female membersacross National Comprehensive Cancer Network (NCCN) guideline panels correlated with the proportion of female authors of seminal treatment-related publications cited in those guidelines. This study was published online in Lancet Oncology.  Studies exploring barriers to the advancement of women in academic medicine…

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

Textured Implants at Sites Other Than the Breast May Increase Risk of Implant-Associated ALCL

A case report describing the diagnosis of anaplastic large cell lymphoma (ALCL) in a woman who underwent cosmetic placement of bilateral, textured silicone gluteal implants was published online in Aesthetic Surgery Journal. 1 The US Food and Drug Administration (FDA) recently issued an update regarding the number of reported cases of breast implant-associated ALCL (BIA-ALCL), a rare form of…

A Growing Focus on Rare Cancers in Phase I Trials

This study was presented at the 2019 International Congress on Targeted Anticancer Therapies (TAT) in Paris, France, from February 25-27, 2019. Dr Jun Sato of the National Cancer Center Hospital, Japan is the lead author of this study.1 Results from a retrospective study evaluating the focus of early-phase clinical trials of investigational drug candidates in…

Next post in General Oncology